Firefly NeuroscienceNASDAQ: AIFF

Profile

Sector:

Technology

Country:

Canada

IPO:

28 November 2002

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$26.43 M
-60%vs. 3y high
18%vs. sector
-vs. 3y high
-vs. sector
-60%vs. 3y high
95%vs. sector
-14.67
-26%vs. 3y high
1%vs. sector

Price

regular market | Fri, 25 Oct 2024 13:30:00 GMT
$3.60+$0.34(+10.43%)

Dividend

No data over the past 3 years
$1.90 M-$389.70 K

Analysts recommendations

Institutional Ownership

Included in screeners

No data

AIFF Latest News

Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
globenewswire.com16 October 2024 Sentiment: POSITIVE

During the Phase 1 study, subjects utilized EEG headsets provided by Firefly partner, Zeto, after which the data was analyzed using Firefly's advanced AI BNA technology analysis platform During the Phase 1 study, subjects utilized EEG headsets provided by Firefly partner, Zeto, after which the data was analyzed using Firefly's advanced AI BNA technology analysis platform

Firefly Neuroscience to Participate in Upcoming October Investor Conferences
globenewswire.com11 October 2024 Sentiment: POSITIVE

TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced that management will participate in the following October 2024 investor conferences:

Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA™ Technology with Zeto's FDA-Cleared EEG Device Platform
globenewswire.com10 September 2024 Sentiment: POSITIVE

Partnership will expand Firefly's FDA Cleared BNA™ technology to more hospitals and physician offices Partnership will expand Firefly's FDA Cleared BNA™ technology to more hospitals and physician offices

Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th
globenewswire.com22 August 2024 Sentiment: POSITIVE

TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) technology company developing innovative neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders, today announced management will host a shareholder update call on Wednesday, September 4, 2024 at 5:00 PM Eastern Time.

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders
globenewswire.com21 August 2024 Sentiment: POSITIVE

NCD Will Integrate Firefly's BNA Technology into its Patient Management Protocols for Enhanced Brain Function Insights and Improved Patient Outcomes NCD Will Integrate Firefly's BNA Technology into its Patient Management Protocols for Enhanced Brain Function Insights and Improved Patient Outcomes

What type of business is Firefly Neuroscience?

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

What sector is Firefly Neuroscience in?

Firefly Neuroscience is in the Technology sector

What industry is Firefly Neuroscience in?

Firefly Neuroscience is in the Software Application industry

What country is Firefly Neuroscience from?

Firefly Neuroscience is headquartered in Canada

When did Firefly Neuroscience go public?

Firefly Neuroscience initial public offering (IPO) was on 28 November 2002

What is Firefly Neuroscience website?

https://fireflyneuro.com

Is Firefly Neuroscience in the S&P 500?

No, Firefly Neuroscience is not included in the S&P 500 index

Is Firefly Neuroscience in the NASDAQ 100?

No, Firefly Neuroscience is not included in the NASDAQ 100 index

Is Firefly Neuroscience in the Dow Jones?

No, Firefly Neuroscience is not included in the Dow Jones index

When was Firefly Neuroscience the previous earnings report?

No data

When does Firefly Neuroscience earnings report?

Next earnings report date is not announced yet